← Evidence map

ArticleAging2023

N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancer.

Mingqi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37437243